Re: Thoughts on ZCC
in response to
by
posted on
Sep 15, 2021 03:05PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
All good points. Hopefully we'll get good news soon and the shares I have been buying will turn out to be a bargain price.